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Bile Duct Involvement by Hepatocellular Carcinoma:  
A Rare Occurrence and Poor Prognostic Indicator  
in Bile Duct Brushing Samples
Shristi Bhattarai1; Rondell P. Graham, MBBS2; Carlie S. Sigel, MD 3; Jiaqi Shi, MD4;  
Raul S. Gonzalez, MD5; Yue Xue, MD6; Alyssa M. Krasinskas, MD6; Kim HooKim, MD7; Volkan Adsay, MD8; 
and Michelle D. Reid, MD 6
BACKGROUND: Hepatocellular carcinoma (HCC) rarely involves the biliary tree and may be inadvertently sampled on bile 
duct brushings (BDBs). METHODS: The pathology archives of 5 institutions were searched for BDBs with HCC involvement. 
RESULTS: A total of 17 BDBs from 14 patients were obtained. There was a male:female ratio of 6:1; the median age of the 
patients was 59.5 years (range, 22-80 years). The median hepatic tumor size was 6.2 cm (range, 2.2-13.0 cm). HCC risk fac-
tors included viral hepatitis (5 patients), cirrhosis (5 patients), hemochromatosis (1 patient), and alcoholic steatohepatitis 
(1 patient). Jaundice with elevated bilirubin, liver enzymes, and α-fetoprotein was common. Endoscopic retrograde cholan-
giopancreatography demonstrated bile duct dilatation, polypoid intraductal masses (5 samples), clots/debris (2 samples), 
or strictures (4 samples). All BDBs had single and clustered large cells with naked atypical nuclei, granular cytoplasm, high 
nuclear/cytoplasmic ratios, and nuclei with prominent macronucleoli. Less common findings included clear/microvesicular 
cytoplasm (35%), papillae (29%), and anisonucleosis (35%). Classic HCC features (widened trabeculae [35%], endothelial 
wrapping [24%], multinucleation [24%], and cytoplasmic bile pigment [35%]) were uncommon. A total of 11 BDBs were diag-
nosed as malignant (10 with HCC and 1 with cholangiocarcinoma), 2 were diagnosed as atypical, and 1 BDB was diagnosed 
as negative; approximately two-thirds were found to have polysomy on fluorescence in situ hybridization. Approximately 
71% of patients died of disease at a median of 3.5 months. CONCLUSIONS: HCC may extend into the intrahepatic and/or 
extrahepatic biliary tree, causing masses and/or strictures that may be sampled on BDB. Although cytologically malignant, 
the classic features of HCC are uncommon, which can cause misdiagnosis. Cytopathologists should be mindful of this dif-
ferential when evaluating BDBs, particularly when concomitant liver masses and/or HCC risk factors are present. Because 
of the associated high mortality and rapid rate of death, its presence should be conveyed clearly in pathology reports.  
Cancer Cytopathol 2019;127:691-699. © 2019 American Cancer Society. 
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INTRODUCTION
The diagnosis of neoplasms in the biliary tree remains a clinical and pathologic challenge, with brush cytology 
and (less frequently) small biopsies being the most frequently used, albeit imperfect, diagnostic tests. The cyto-
logic diagnosis of malignancy often is confounded by well-differentiated cytologically bland carcinoma, as well 
as instrumentation-related and cholangitis-related reactive changes.1,2
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Nonetheless, the majority of biliary tract tumors that 
are diagnosed on bile duct brushing samples (BDBs) or 
intraductal biopsy either are pancreatic (pancreatic duc-
tal adenocarcinoma) or biliary (intrahepatic and extrahe-
patic cholangiocarcinoma) in origin.3-6 Other sources of 
positive results are intraductal papillary neoplasms of the 
bile duct, primary tumoral intraductal neoplasms of the 
intrahepatic and extrahepatic biliary tree, and metastatic 
nonpancreatobiliary tumors from the upper and lower 
gastrointestinal tract, and even the lung.4-6 In addition to 
metastases from distant sites, the biliary tract also may be 
involved by direct extension of hepatocellular carcinoma 
(HCC).
Intraductal spread of HCC into the biliary tract is 
an unusual source of malignant cells on BDBs.7-11 To our 
knowledge, the question of whether this is due to the rar-
ity of involvement or to the failure of cytopathologists to 
recognize tumor in these specimens is unclear, but when 
contrasted with the number of new cases of HCC world-
wide (estimated at 841,080 in 2018), it is surprising that 
this phenomenon is not encountered more frequently.12 
In the current study, we sought to examine the clinico-
pathologic characteristics of patients with BDBs demon-
strating HCC.
MATERIALS AND METHODS
A multi-institutional search of the pathology depart-
ment archives of 5 large tertiary institutions (Beth Israel 
Deaconess Medical Center [Boston, Massachusetts], 
Emory University [Atlanta, Georgia; institutional re-
view board approval IRB00095765], the Mayo Clinic 
[Rochester Minnesota], Memorial Sloan Kettering Cancer 
Center [New York City], and the University of Michigan 
[Ann Arbor, Michigan]) was conducted for BDBs in 
which HCC was identified either on initial review or on 
re-review triggered by a concurrent or subsequent positive 
liver biopsy or surgical resection. Clinicopathologic data, 
radiologic findings, and cytogenetic and cytohistologic 
features from cytology samples and concurrent or subse-
quent biopsies and/or surgical resections (when available) 
were collected for all patients. Cytology specimens were 
re-examined for cytologic features that historically have 
been described in HCC, including specimen hypercellu-
larity, increased nuclear/cytoplasmic ratio, singly dispersed 
atypical naked nuclei, macronucleoli, multinucleated 
tumor cells, endothelial wrapping (well-defined vessels 
traversing tissue fragments), widened trabeculae >2 cell 
plates in thickness, and cytoplasmic bile pigment.13,14 In 
addition, the presence of malignant-appearing single cells 
with preserved granular “oncocytoid” or clear/microvesic-
ular cytoplasm, nuclear pleomorphism or anisonucleosis, 
an increased nuclear/cytoplasmic ratio, papillae, necrosis, 
multinucleated tumor giant cells, and a 2-cell population 
of oncocytoid cells with abundant granular cytoplasm and 
ductal cells (singly dispersed columnar cells or in honey-
comb sheets) was noted.
RESULTS
Clinical Characteristics
Of >5000 BDBs collected from the 5 institutions over 
>20 years, a total of 17 BDBs with HCC were identified 
among 14 patients. Specimen contribution by institution 
was 2 specimens each from the University of Michigan 
and the Mayo Clinic, 3 specimens from Memorial 
Sloan Kettering Cancer Center, 4 specimens from Beth 
Israel Deaconess Medical Center, and 6 specimens from 
Emory University. These 17 samples were identified 
from 12 males and 2 females (male:female ratio of 6:1) 
with a median age of 59.5  years (range, 22-80  years). 
Eight patients presented with jaundice, 13 had elevated 
serum bilirubin, all patients had elevated liver enzymes, 
5 patients had elevated serum α-fetoprotein levels, and 
2 patients had elevated serum CA 19-9 and carcinoem-
bryonic antigen. Risk factors for HCC were noted in 10 
patients, including hepatitis B virus infection (2 pa-
tients), hepatitis C virus infection (3 patients), hereditary 
hemochromatosis (1 patient), alcoholic steatohepatitis 
with cirrhosis (1 patient), nonalcoholic steatohepatitis 
(1 patient), and cirrhosis without obvious etiology 
(2 patients). Three patients were clinically suspected 
of having recurrent HCC at the time of BDB because 
they previously had been diagnosed with and success-
fully treated for HCC years earlier. These individuals 
included one patient each with hemochromatosis and 
alcoholic steatohepatitis and a 22-year-old patient with a 
history of fibrolamellar HCC.
Radiologic Findings
Imaging results (including computed tomography and 
magnetic resonance imaging) were available in all cases 
and are summarized in Table 1. A hepatic mass (or 
masses) was noted on imaging in 12 patients. Hepatic 
tumors ranged in size from 2.2  cm to 13.0  cm with a 
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median size of 6.2 cm. Intrahepatic and/or extrahepatic 
bile duct dilatation with or without involvement of the 
common bile duct was observed in 8 patients (57%) and 
portal vein thrombosis was noted in 3 patients (21%). 
Documented radiologic diagnoses included HCC (6 pa-
tients), cholangiocarcinoma (6 patients), and HCC ver-
sus intrahepatic cholangiocarcinoma (2 patients). One 




The results of endoscopic retrograde cholangiopan-
creatography (ERCP) were available for review in 13 
patients. These demonstrated variable findings, includ-
ing papillary or polypoid intraductal lesions (7 patients; 
described as papillary, polypoid, frond-like masses [5 
patients]; debris [1 patient]; or clots [1 patient]), as 
well as strictures of the hepatic or common bile duct 
without masses (4 patients). Two patients were found 
to have no intraductal masses, strictures, or other duct 
abnormalities on ERCP.
Cytologic Findings
All patients had BDBs of the intrahepatic, extrahepatic, 
or common bile duct, and 2 patients had brushings of 
both the intrahepatic and common bile ducts. Sixteen 
samples had ThinPrep slides (14 with cell blocks and 
2 without) and 1 sample had hematoxylin and eosin–
stained smears only. Various immunohistochemical stains 
(including pancytokeratin, cytokeratin 7, arginase, hepat-
ocyte paraffin [Hep-Par], and glypican 3) and reticulin 
were performed on 10 specimens. Eleven specimens were 
termed “malignant” on cytology, one was misinterpreted 
as benign, and 2 specimens were classified as “atypical 
cells present.” Of the 11 cases classified as malignant on 
the BDB, 9 (82%) were diagnosed as HCC, 1 (9%) as 
“favor HCC,” and 1 (9%) as adenocarcinoma (intrahe-
patic cholangiocarcinoma).
Cytologic findings that were found to be present in 
80% to 100% of samples included 3-dimensional clus-
ters and singly dispersed atypical cells with naked nuclei 
or abundant granular cytoplasm (Figs. 1 and 2). Cells 
often had a high nuclear/cytoplasmic ratio (77%) with 
round to oval nuclei (nuclear irregularity was noted in 
  
Figure 1. ThinPrep slides. (A) A mixed (2-cell) population of benign ductal cells in honeycomb sheets (Top Center) and single and 
clustered malignant cells (Center) with abundant granular cytoplasm, round nuclei, and cherry red macronucleoli (Papanicolaou 
stain, original magnification ×200). (B) Tumor cells demonstrating a high nuclear/cytoplasmic ratio, granular to clear cytoplasm, and 
round hypochromatic and hyperchromatic nuclei with cherry red macronucleoli (Papanicolaou stain, original magnification ×600). 
(C) Large hyperchromatic tumor cells with (Left) dense polygonal cytoplasm and (Right) naked nuclei (Papanicolaou stain, original 
magnification ×600). (D) Three-dimensional cluster with hypochromasia and markedly irregular nuclear membranes. This case was 
misdiagnosed as adenocarcinoma (Papanicolaou stain, original magnification ×400).
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35% of samples) and prominent central nucleoli were 
seen in the majority of cases (94%) (Figs. 1 and 2). Less 
common cytologic findings included necrosis (47%), 
a second population of benign-appearing ductal cells 
(47%), hypercellularity (41%), anisonucleosis of ≥4-fold 
(35%) (Figs. 1 and 2), clear or bubbly microvesicular 
pale cytoplasm (35%), and papillary groups (29%) 
(Figs. 3 and 4). Classic cytologic features of HCC such 
as widened trabeculae (35%), endothelial wrapping 
(24%), cytoplasmic bile pigment (24%), and multinu-
cleated malignant cells (24%) were observed less fre-
quently (Figs. 2 and 3). Widened trabeculae were best 
observed in cell blocks, highlighted by reticulin stain-
ing and positive for the hepatocellular differentiation 
markers arginase or Hep-Par (Fig. 4). Occasional cases 
(29%) demonstrated variably sized “papillary groups” 
lined by epithelial cells with abundant eosinophilic 
granular to clear cytoplasm (Fig. 4), focally resembling 
a steatohepatitic HCC (Fig. 4). The mixed HCC-
cholangiocarcinoma case demonstrated single intact 
cells and naked atypical nuclei as well as 3-dimensional 
clusters of malignant cells with abundant granular or 
clear cytoplasm and round to oval nuclei with macronu-
cleoli (Fig. 1) and focal nuclear membrane irregularity. 
Cytologic features of the cases are highlighted in Figures 
1‒4 and summarized in Table 2.
Histologic Findings
Eleven patients underwent concurrent liver biopsies at 
the time of BDB. The diagnosis of HCC was confirmed 
in 10 patients, including the fibrolamellar variant, and 
the tumors ranged from well to poorly differentiated. 
On biopsy, one tumor demonstrated a mixed HCC-
cholangiocarcinoma but the corresponding BDB showed 
only large cells with granular cytoplasm and central round 
nuclei with macronucleoli consistent with the HCC com-
ponent. Only one tumor was resected and demonstrated 
a pT3b, poorly differentiated HCC with lymphovascular 
invasion and intraductal growth of tumor (Fig. 4).
Fluorescence In Situ Hybridization
Fluorescence in situ hybridization (FISH) was performed 
on 3 specimens and was “positive” in 2 cases, both of 
which demonstrated polysomy (one by Vysis UroVysion 
FISH demonstrating >5 cells with ≥2 chromosomes 
[chromosomes 3, 7, and 17] and the other by a pancrea-
tobiliary FISH probe kit that demonstrated gains of ≥2 
loci of 1q21, 7p12, 8q24, and 9p21). Both cases found to 
Figure 2. ThinPrep slides showing (A) a well-differentiated hepatocellular carcinoma with monotonous tumor cells with a low 
nuclear/cytoplasmic ratio and clear cytoplasm (Papanicolaou stain, original magnification ×400). Examples of poorly differentiated 
hepatocellular carcinoma showing (B) marked (>5-fold) anisonucleosis, (C) multinucleated tumor giant cells, and (D) cytoplasmic 
bile pigment (Papanicolaou stain, original magnification ×600).
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Figure 3. Hepatocellular carcinoma with tumor cells arranged in widened trabeculae >2 cells in thickness is shown in panels A (H & E, 
original magnification ×40) and B (Papanicolaou stain, original magnification ×400). (C) Widened trabeculae were focally lined 
by flattened endothelial cells (arrow) (Papanicolaou stain, original magnification ×400). (D) A cell block demonstrating well-
differentiated hepatocellular carcinoma (H & E, original magnification ×200).
Figure 4. (A and B) Cell blocks demonstrating papillary units with central hyalinized cores lined with multilayered, large, eosinophilic 
to clear cells with relative monotony (H & E, original magnification ×200-×400). (C) Reticulin stain highlighting widened trabeculae 
(original magnification ×200). Tumor cells were (D) positive for arginase and negative for cytokeratin 7 whereas (E) the benign 
ductal cells (Upper Right) were positive (original magnification ×200). (F) Hepatectomy specimen showing tumor growing as 
a circumscribed, nodular, intraductal mass that compressed the duct wall. Note the presence of dark blue drug-eluting bead 
transarterial chemoembolization (DEB TACE) spherules on the lower right (H & E stain, original magnification ×40).
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be positive on FISH were poorly differentiated, 1 tumor 
measured 8.0 cm and the other measured 11.3 cm, and 
both patients had chronic viral hepatitis.
Follow-Up Information
Follow-up information was available for all patients and 
ranged from 0.2 months to 49 months, with a median 
of 3.5 months. Ten patients (71%) died of disease, 3 pa-
tients (21%) were alive with disease at the time of last 
follow-up, and 1 patient (7%) was lost to follow-up at 
49 months. It is interesting to note that of the 10 patients 
who died, the median survival was 3.5  months (range, 
1-46  months) and 6 of these patients (60%) died 1 to 
5  months after diagnosis. Of the 6 patients who died 
within 5 months of diagnosis, 1 patient had a very small 
(2.0 cm) and purely intraductal HCC.
DISCUSSION
To the best of our knowledge, the extension of HCC 
into the intrahepatic and extrahepatic biliary tree first 
was described in 1947 by Mallory et al15 and is known 
historically by names such as “icteric-type hepatoma”16 
and “cholestatic HCC.”17 When this occurs, it leads to 
the patient presenting with jaundice, elevated serum 
bilirubin, and elevated liver enzymes, symptoms and 
signs that were observed in greater than one-half of the 
patients in the current study cohort. Serum α-fetoprotein 
may or may not be elevated, which, in the absence of 
a liver mass, may delay diagnosis and confound radi-
ologists and gastroenterologists. Obstructive jaundice 
as the main presentation in patients with HCC occurs 
in 1% to 12% of patients.18 Early identification is 
important because patients may benefit from early surgi-
cal intervention.19
Ductal obstruction in HCC is due either to the 
intraductal accumulation of clots (hemobilia) or debris 
or intraductal tumor growth, duct wall invasion, or ex-
ternal compression by an expansile tumor.19 The intra-
ductal component may be contiguous with the hepatic 
tumor or may be completely separate, with or without 
mucosal attachment.20 There even are reports of HCC 
occurring entirely within the biliary tree without a dis-
cernable hepatic component, independent of size and 
differentiation.21-23 Several of the cases in the current 
study were morphologically well differentiated, nearly 
one-half of the tumors measured ≤5.0  cm, and 14% 
demonstrated pure intraductal growth. To our knowl-
edge, the majority of intraductal tumors are pure HCCs, 
but mixed HCC-cholangiocarcinomas also have been 
described.24,25 Ductal involvement by HCC is not eas-
ily identifiable on computed tomography and magnetic 
resonance imaging but is more obvious on ERCP, which 
also allows for direct visualization and sampling of pol-
ypoid masses or strictures.19 Because of its rarity and 
subtle appearance, tumors either are missed by gastro-
enterologists or misinterpreted as cholangiocarcinoma 
TABLE 2. Cytologic Findings in 17 Bile Duct Brushing Samples
Feature 1 2 3 4 5a 6a 7 8 9a 10a 11 12 13 14 15 16a 17a Total
Hypercellularity     + +       + + +   +     +     7 (41%)
Single intact cells + + + + + + + + + + + + + + + + + 17 (100%)
Atypical naked nuclei + + + + + + + + + + + + + + + + + 17 (100%)
3-dimensional clusters + + + + + + + + + + + + + + + + + 17 (100%)
Granular cytoplasm + + + + + + + + + + + + + + + + + 17 (100%)
Prominent nucleoli + + + + + + + +   + + + + + + + + 16 (94%)
Widened trabeculae                 + + +   + + +     6 (35%)
High N/C ratio + + + +     + + + + + + + + +     13 (77%)
Necrosis       + + + + +         + + +     8 (47%)
2-cell population       +       +       + + + + + + 8 (47%)
Hypercellularity     + +       + + +   +     +     7 (41%)
Clear/microvesicular 
cytoplasm
    +   + +   + + +               6 (35%)
Cytoplasmic bile       +     +             + + + + 6 (35%)
Nuclear irregularity     +   + +     + +   +           6 (35%)
Anisonucleosis       + +     +       +       + + 6 (35%)
Papillary groups       + + + +     +               5 (29%)
Multinucleated tumor cells       +   + +   +                 4 (24%)
Endothelial wrapping       +       +       +     +     4 (24%)
Ancillary studies (IHC/reticulin)       + + + + + + + +   + +       10 (59%)
Abbreviations: IHC, immunohistochemistry (immunohistochemical stains including hepatocyte paraffin (Hep-Par), glypican 3, and arginase); N/C ratio, nuclear/
cytoplasmic ratio.
aSamples 5 and 6 were from the same patient, samples 9 and 10 were from the same patient, and samples 16 and 17 were from the same patient.
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or choledocholithiasis.26,27 Intraductal involvement by 
HCC is associated with a poor prognosis,19 which was 
observed in the current study, in which 70% of the study 
cohort died within 6 months of diagnosis.
The presence of HCC in BDBs also has been de-
scribed in isolated reports, with the current study rep-
resenting what to our knowledge is the largest series to 
date in the cytology literature.9-11,25,28 The most fre-
quent cytologic features that we identified herein were 
singly dispersed, intact, and 3-dimensional clusters of 
polygonal tumor cells with well-defined cell borders; 
a relatively high nuclear/cytoplasmic ratio; abundant 
granular oncocytoid cytoplasm; and round to oval cen-
tral nuclei with variable chromatin (hyperchromatic and 
hypochromatic) and prominent, often macro-, nucleoli. 
Widened trabeculae (which we defined as hepatic plates 
that were >2 cells in thickness) with clearly delineated 
endothelial lining cells were observed only rarely, as was 
intracytoplasmic bile, features that typically would favor 
HCC over cholangiocarcinoma. The fact that the major-
ity of the samples in the current study were liquid-based 
preparations and had limited cellularity as well as necrosis 
may have contributed to the difficulty in finding intact 
trabeculae and clinging endothelial cells. These features 
were best seen on cell blocks but the cell blocks often were 
paucicellular and bloody. In addition, because of their 
monotony, more well-differentiated examples of HCC 
may be mistakenly classified as benign or indeterminate 
on BDBs, which happened in 3 of the cases in the current 
study. Although the majority of cases in the current study 
were diagnosed accurately on cytology, approximately 
60% required ancillary immunocytochemical stains, in-
cluding arginase and Hep-Par to confirm their hepato-
cellular phenotype and/or reticulin (Fig. 4) to confirm 
hepatic plate expansion.
HCC in BDBs must be distinguished from other 
lesions that more typically involve the intrahepatic and 
extrahepatic biliary tree and potentially could mimic 
HCC morphologically. By virtue of its intraductal 
location, HCC must be distinguished from an invasive 
cholangiocarcinoma, which is far more frequent at this 
anatomic site. Although the intracytoplasmic mucin vac-
uoles that are typical of adenocarcinoma were not noted 
in any of the cases in the current study, cytoplasmic clear-
ing (clear cell or steatohepatitic features) was present in 
some samples, and potentially could cause confusion with 
cholangiocarcinoma, as it did in one case herein. Tumor 
cell negativity for hepatocellular immunocytochemical 
markers as well as the absence of cytoplasmic bile pig-
ment should help with distinguishing between the two 
entities. However, mixed HCC-cholangiocarcinoma may 
be impossible to distinguish from pure HCC in BDBs 
and may require examination of a larger sample. Other 
intraductal neoplasms that may demonstrate eosino-
philic cells similar to those of HCC include intraductal 
papillary neoplasm of the bile duct, particularly the on-
cocytic type, and oncocytic-type intraductal papillary 
mucinous neoplasm of the pancreas, which may involve 
the biliary tree.29-32 Both are characterized by papillary 
units lined by oncocytic cells with large nuclei, promi-
nent nucleoli, and little if any cytoplasmic mucin. These 
features may mimic the papillae observed in some of the 
current study cases. Endothelial wrapping, cytoplasmic 
bile pigment, and positive hepatocellular markers would 
favor HCC. Well-differentiated neuroendocrine tumors 
often metastasize to the liver or may involve bile ducts, 
and when oncocytic they may mimic HCC.33,34 Unlike 
HCC, well-differentiated neuroendocrine tumors have 
eccentric nuclei and salt-and-pepper chromatin, and stain 
with neuroendocrine markers.34 The distinction between 
well-differentiated HCC and normal hepatocytes, which 
also may be sampled on BDBs, can be especially chal-
lenging. Identifying widened trabeculae with endothelial 
wrapping, nuclear pleomorphism, and macronucleoli 
should favor HCC over benign hepatic parenchyma, but 
this distinction ultimately may require biopsy.13,14
When HCC involves the biliary tree, it can lead to 
obstructive jaundice, ductal dilatation, and liver enzyme 
abnormalities, requiring ERCP and BDB, which may 
inadvertently sample these tumors. BDBs are characterized 
by cells with naked nuclei or abundant granular cytoplasm, 
a high nuclear/cytoplasmic ratio, large nuclei, and macronu-
cleoli. The classic cytologic features of HCC usually noted 
on aspiration (endothelial wrapping, widened trabeculae, 
and cytoplasmic bile) are infrequent findings when using 
this sampling modality. To avoid misdiagnosis, cytopathol-
ogists should have a high index of suspicion when evaluat-
ing these samples, particularly in patients with concomitant 
liver lesions or known risk factors for HCC.
FUNDING SUPPORT
No specific funding was disclosed.
699Cancer Cytopathology  November 2019
Bile Duct Involvement by HCC/Bhattarai et al
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
AUTHOR CONTRIBUTIONS
Shristi Bhattarai: Data curation, formal analysis, methodology, 
and writing–review and editing. Rondell P. Graham: Case contri-
bution, data curation, formal analysis, investigation, methodology, 
and writing–review and editing. Carlie S. Sigel: Case contribu-
tion, data curation, formal analysis, investigation, methodology, 
and writing–review and editing. Jiaqi Shi: Case contribution, 
data curation, formal analysis, investigation, methodology, and 
writing–review and editing. Raul S. Gonzalez: Case contribution, 
data curation, formal analysis, investigation, methodology, and 
writing–review and editing. Yue Xue: Case contribution, formal 
analysis, investigation, methodology, and writing–review and edit-
ing. Alyssa M. Krasinskas: Case contribution and writing–review 
and editing. Kim HooKim: Formal analysis, investigation, meth-
odology, and writing–review and editing. Volkan Adsay: Case con-
tribution, formal analysis, methodology, and writing–review and 
editing. Michelle D. Reid: Case contribution, conceptualization, 
data curation, formal analysis, writing–original draft, writing– 
review and editing, and supervision.
REFERENCES
 1. Layfield LJ, Wax TD, Lee JG, Cotton PB. Accuracy and morpho-
logic aspects of pancreatic and biliary duct brushings. Acta Cytol. 
1995;39:11-18.
 2. Logrono R, Kurtycz D, Molina C, Trivedi V, Wong J, Block K. 
Analysis of false-negative diagnoses on endoscopic brush cytol-
ogy of biliary and pancreatic duct strictures. Arch Pathol Lab Med. 
2000;124:387-392.
 3. Choi WT, Swanson PE, Grieco VS, Wang D, Westerhoff M. The out-
comes of “atypical” and “suspicious” bile duct brushings in the iden-
tification of pancreaticobiliary tumors: follow-up analysis of surgical 
resection specimens. Diagn Cytopathol. 2015;43:885-891.
 4. Okonkwo AM, De Frias DV, Gunn R, et al. Reclassification of “atypi-
cal” diagnoses in endoscopic retrograde cholangiopancreaticography–
guided biliary brushings. Acta Cytol. 2003;47:435-442.
 5. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and 
bile duct brushing cytology in 1000 cases: review of findings and com-
parison of preparation methods. Cancer. 2006;108:231-238.
 6. Hacihasanoglu E, Memis B, Pehlivanoglu B, et al. Factors impact-
ing the performance characteristics of bile duct brushings: a clini-
co-cytopathologic analysis of 253 patients. Arch Pathol Lab Med. 
2018;142:863-870.
 7. Rupp M, Hawthorne CM, Ehya H. Brushing cytology in biliary tract 
obstruction. Acta Cytol. 1990;34:221-226.
 8. Vadmal MS, Byrne-Semmelmeier S, Smilari TF, Hajdu SI. Biliary 
tract brush cytology. Acta Cytol. 2000;44:533-538.
 9. Dusenbery D. Biliary stricture due to hepatocellular carcinoma: diag-
nosis by bile duct brushing cytology. Diagn Cytopathol. 1997;16:55-56.
 10. Schmelzle M, Matthaei H, Lehwald N, et al. Extrahepatic intraductal 
ectopic hepatocellular carcinoma: bile duct filling defect. Hepatobiliary 
Pancreat Dis Int. 2009;8:650-652.
 11. Fu LY, Mitchell KA, Cai G. Clear cell hepatocellular carcinoma 
diagnosed by bile duct brushing cytology. Diagn Cytopathol. 
2016;44:147-151.
 12. Torbenson MS, Ng IOL, Park YN, Roncalli M, Sakamato M. 
Hepatocellular carcinoma. In: WHO Classification of Tumours 
Editorial Board, ed. WHO Classification of Tumours: Digestive 
System Tumours. 5th ed. IARC Press; 2019:229-239.
 13. Das DK. Cytodiagnosis of hepatocellular carcinoma in fine-needle 
aspirates of the liver: its differentiation from reactive hepatocytes and 
metastatic adenocarcinoma. Diagn Cytopathol. 1999;21:370-377.
 14. de Boer WB, Segal A, Frost FA, Sterrett GF. Cytodiagnosis of well 
differentiated hepatocellular carcinoma: can indeterminate diagnoses 
be reduced? Cancer. 1999;87:270-277.
 15. Mallory TB, Castleman B, Parris BE. Case records of the Massachusetts 
General Hospital. N Engl J Med. 1947;237:673-676.
 16. Lin TY, Chen KM, Chen YR, Lin WS, Wang TH, Sung JL. Icteric 
type hepatoma. Med Chir Dig. 1975;4:267-270.
 17. Okuda K. Clinical aspects of hepatocellular carcinoma: analysis of 
134 cases. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. 
John Wiley & Sons; 1976:387-436.
 18. Kew MC, Paterson AC. Unusual clinical presentations of hepatocellu-
lar carcinoma. Trop Gastroenterol. 1985;6:10-22.
 19. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaun-
dice: diagnosis, treatment and prognosis. World J Gastroenterol. 
2003;9:385-391.
 20. Narita R, Oto T, Mimura Y, et al. Biliary obstruction caused by intra-
biliary transplantation from hepatocellular carcinoma. J Gastroenterol. 
2002;37:55-58.
 21. Buckmaster MJ, Schwartz RW, Carnahan GE, Strodel WE. 
Hepatocellular carcinoma embolus to the common hepatic duct with 
no detectable primary hepatic tumor. Am Surg. 1994;60:699-702.
 22. Cho HG, Chung JP, Lee KS, et al. Extrahepatic bile duct hepatocel-
lular carcinoma without primary hepatic parenchymal lesions–a case 
report. Korean J Intern Med. 1996;11:169-174.
 23. Soyer P, Laissy JP, Bluemke DA, Sibert A, Menu Y. Bile duct in-
volvement in hepatocellular carcinoma: MR demonstration. Abdom 
Imaging. 1995;20:118-121.
 24. Saito M, Hige S, Takeda H, Tomaru U, Shibata M, Asaka M. 
Combined hepatocellular carcinoma and cholangiocarcinoma grow-
ing into the common bile duct. J Gastroenterol. 2001;36:842-847.
 25. Dusenbery D. Combined hepatocellular-cholangiocarcinoma. 
Cytologic findings in four cases. Acta Cytol. 1997;41:903-909.
 26. Jan YY, Chen MF. Obstructive jaundice secondary to hepatocellular 
carcinoma rupture into the common bile duct: choledochoscopic 
findings. Hepatogastroenterology. 1999;46:157-161.
 27. Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima 
T. Hepatocellular carcinoma presenting as intrabile duct tumor 
growth: a clinicopathologic study of 24 cases. Cancer. 1982;49: 
2144-2147.
 28. Kunz G Jr, Chung J, Ali SZ. Hepatocellular carcinoma–fibrola-
mellar variant: cytopathology of an unusual case. Diagn Cytopathol. 
2002;26:257-261.
 29. Reddy K, Hooper K, Frost A, et al. Intraductal papillary car-
cinoma of common bile duct diagnosed by endoscopic ultra-
sound–guided fine-needle aspiration. Endoscopy. 2014;46(suppl 1 
UCTN):E248-E249.
 30. Reid MD, Stallworth CR, Lewis MM, et al. Cytopathologic diagnosis 
of oncocytic type intraductal papillary mucinous neoplasm: criteria 
and clinical implications of accurate diagnosis. Cancer Cytopathol. 
2016;124:122-134.
 31. Jurczyk MF, Zhu B, Villa C, DeFrias D, Lin X. Cytomorphology of in-
traductal oncocytic papillary neoplasm of the liver. Diagn Cytopathol. 
2014;42:895-898.
 32. Bansal A, Thung SN, Zhu H, Schwartz M, Lewis S. Synchronous 
pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma aris-
ing in the context of intraductal papillary neoplasms. Clin Imaging. 
2016;40:897-901.
 33. Volante M, La Rosa S, Castellano I, Finzi G, Capella C, Bussolati 
G. Clinico-pathological features of a series of 11 oncocytic endocrine 
tumours of the pancreas. Virchows Arch. 2006;448:545-551.
 34. Chen S, Wang X, Lin J. Fine needle aspiration of oncocytic variants 
of pancreatic neuroendocrine tumor: a report of three misdiagnosed 
cases. Acta Cytol. 2014;58:131-137.
